Scutellarin Prevents Nonalcoholic Fatty Liver Disease (NAFLD) and Hyperlipidemia via PI3K/AKT-Dependent Activation of Nuclear Factor (Erythroid-Derived 2)-Like 2 (Nrf2) in Rats

Related articles

09 Jun 2020 : Errate

Erratum: The p66shc-Mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease

Jing Zhang, Yanpeng Li, [...] Bingyuan Wang, Yan Luo, Junping Shi, Baiyun Zhao - Show fewer authors

DOI: 10.12659/MSM.926160

01 Jun 2020 : Clinical Research

Analysis of Risk Factors for Adverse Cardiovascular Events in Elderly Patients with Acute Myocardial Infarction and Non-Alcoholic Fatty Liver Disease (NAFLD)

Wei Xia, Ning Yang, [...] Yuming Li - Show fewer authors

DOI: 10.12659/MSM.922913

28 Jun 2020 : Database Analysis

Key genes associated with non-alcoholic fatty liver disease and acute myocardial infarction

Weiran Dai, Yue Sun, [...] Zhiyuan Jiang, Kuan Du, Ning Xia, Guoqiang Zhong - Show fewer authors

DOI: 10.12659/MSM.922492

19 Mar 2020 : Laboratory Research

The p66shc-Mediated Regulation of Hepatocyte Senescence Influences Hepatic Steatosis in Nonalcoholic Fatty Liver Disease

Jing Zhang, Yanpeng Li, [...] Bingyuan Wang, Yan Luo, Junping Shi, Baiyun Zhao - Show fewer authors

DOI: 10.12659/MSM.921887

29 Jan 2020 : Case report

Acute Fatty Liver of Pregnancy: Rare, but Potentially Fatal

Andreia de Vasconcelos Gaspar, Tânia C. Ascensão, [...] Isabel Santos Silva - Show fewer authors

DOI: 10.12659/AJCR.921122

06 Feb 2020 : Animal Research

The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid

Jinshan Wang, Wentao Jiang

DOI: 10.12659/MSM.919220

23 Dec 2019 : Clinical Research

Evaluation of Plateletcrit and Platelet Distribution Width in Patients with Non-Alcoholic Fatty Liver Disease: A Retrospective Chart Review Study

Alihan Oral, Tolga Sahin, [...] Fatih Turker, Erdem Kocak - Show fewer authors

DOI: 10.12659/MSM.920172

23 Apr 2019 : Laboratory Research

Transcriptional Regulation of Early Growth Response Gene-1 (EGR1) is Associated with Progression of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients with Insulin Resistance

Zedong Li, Peng Yu, [...] Jiajia Wu, Fang Tao, Jun Zhou - Show fewer authors

DOI: 10.12659/MSM.914044

08 Feb 2019 : Meta-Analysis

Correlation Between Adiponectin Gene rs1501299 Polymorphism and Nonalcoholic Fatty Liver Disease Susceptibility: A Systematic Review and Meta-Analysis

Jiaxing Liu, Jicheng Xing, [...] Bing Wang, Changyong Wei, Ruining Yang, Yuerong Zhu, Hong Qiu - Show fewer authors

DOI: 10.12659/MSM.912737

18 Sep 2018 : Laboratory Research

Tetrahydropalmatine Prevents High-Fat Diet-Induced Hyperlipidemia in Golden Hamsters (Mesocricetus Auratus)

Caihua Sun, Zhiyun Chen, [...] Hui Wang, Ke Ding - Show fewer authors

DOI: 10.12659/MSM.910578

26 Nov 2018 : Animal Research

The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN)

Jianlong Gao, Rui Xiong, [...] Dan Xiong, Wenxing Zhao, Sheng Zhang, Tao Yin, Xinhua Zhang, Guozhen Jiang, Zhengyu Yin - Show fewer authors

DOI: 10.12659/MSM.910544

01 Oct 2018 : Clinical Research

Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH)

Jiayu Wu, Ruinan Zhang, [...] Feng Shen, Ruixu Yang, Da Zhou, Haixia Cao, Guangyu Chen, Qin Pan, Jiangao Fan - Show fewer authors

DOI: 10.12659/MSM.909747

14 Jul 2017 : Animal Research

Effects of an Enriched Extract of Paeoniflorin, a Monoterpene Glycoside used in Chinese Herbal Medicine, on Cholesterol Metabolism in a Hyperlipidemic Rat Model

Huiming Hu, Qiaoqiao Zhu, [...] Jie Su, Yajun Wu, Yanchen Zhu, Yin Wang, Hui Fang, Minxia Pang, Bo Li, Suhong Chen, Guiyuan Lv - Show fewer authors

DOI: 10.12659/MSM.905544

20 Feb 2018 : Laboratory Research

Paeoniflorin Inhibits Receptor Activator for Nuclear Factor κB (RANK) Ligand-Induced Osteoclast Differentiation In Vitro and Particle-Induced Osteolysis In Vivo

Zhuokai Li, De Li, [...] Xiaodong Chen - Show fewer authors

DOI: 10.12659/MSM.907739

26 Nov 2017 : Clinical Research

PI3K-Akt Signal Transduction Molecules Maybe Involved in Downregulation of Erythroblasts Apoptosis and Perifosine Increased Its Apoptosis in Chronic Mountain Sickness

Chengyu Zhao, Zhanquan Li, [...] Linhua Ji, Jie Ma, Ri-Li Ge, Sen Cui - Show fewer authors

DOI: 10.12659/MSM.905739

21 Sep 2017 : Laboratory Research

Hepatitis C Virus Infection Increases c-Jun N-Terminal Kinase (JNK) Phosphorylation and Accentuates Hepatocyte Lipoapoptosis

Hiroko Takaki, Yuko Akazawa, [...] Youko Kido, Mami Morishita, Takuya Honda, Hidetaka Shibata, Satoshi Miuma, Hisamitsu Miyaaki, Naota Taura, Hisayoshi Kondo, Kazuhiko Nakao - Show fewer authors

DOI: 10.12659/MSM.903210

16 May 2017 : Laboratory Research

MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR)

Xianchao An, Zonglin Yang, [...] Zhengzhuang An - Show fewer authors

DOI: 10.12659/MSM.901377

19 Oct 2016 : Clinical Research

Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1

Ran Ao, Ying Wang, [...] Jing Tong, Bai-Fang Wang - Show fewer authors

DOI: 10.12659/MSM.897207

29 Aug 2014 : Original article

Deterioration of Heart Rate Recovery Index in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)

Olcay Ozveren, Orhan Dogdu, [...] Cihan Sengul, Veysel Cinar, Elif Eroglu, Zekeriya Kucukdurmaz, Muzaffer Degertekin - Show fewer authors

DOI: 10.12659/MSM.890741

16 Dec 2013 : Original article

Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes

Aleksandra Trojak, Małgorzata Waluś-Miarka, [...] Ewa Woźniakiewicz, Maciej T. Małecki, Barbara Idzior-Waluś - Show fewer authors

DOI: 10.12659/MSM.889649

01 Dec 2012

The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease

Halina Cichoż-Lach, Krzysztof Celiński, [...] Beata Prozorow-Król, Jarosław Swatek, Maria Słomka, Tomasz Lach - Show fewer authors

DOI: 10.12659/MSM.883601

23 Apr 2012

The prevalence of metabolic risk factors among outpatients with diagnosed nonalcoholic fatty liver disease in Lithuania

Jonas Valantinas, Daiva Asta Apanaviciene, [...] Ligita Maroziene, Audrius Sveikata - Show fewer authors

DOI: 10.12659/MSM.882722

24 Apr 2011

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease

Yasar Colak, Oguzhan Ozturk, [...] Ebubekir Senates, Ilyas Tuncer, Elif Yorulmaz, Gupse Adali, Levent Doganay, Feruze Yilmaz Enc - Show fewer authors

DOI: 10.12659/MSM.881749

01 Dec 2009

Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease

Tatjana Abel, Janos Feher, [...] Elek Dinya, Mohamed Gamal Eldin, Attila Kovacs - Show fewer authors

25 Sep 2009

Clinical effectiveness of ezetimibe for a non-obese patient with nonalcoholic fatty liver disease

Munechika Enjoji, Masatake Tanaka, [...] Masayuki Miyazaki, Nobito Higuchi, Masaki Kato, Kazuhiro Kotoh, Kazuhisa Matsunaga, Takuya Nishinakagawa, Kazuyuki Machida, Manabu Nakashima, Makoto Nakamuta - Show fewer authors

30 Mar 2009

Elevated serum levels of caspase-cleaved cytokeratin 18 (CK18-Asp396) in patients with nonalcoholic steatohepatitis and chronic hepatitis C

Yusuf Yilmaz, Enver Dolar, [...] Engin Ulukaya, Semra Akgoz, Murat Keskin, Murat Kiyici, Omer Yerci, Arzu Yilmaztepe Oral, Cuma Bulent Gul, Selim Gurel, Selim Giray Nak, Macit Gulten - Show fewer authors

30 Mar 2009

Dipeptidyl peptidase IV inhibitors: therapeutic potential in nonalcoholic fatty liver disease

Yusuf Yilmaz, Ozlen Atug, [...] Oya Yonal, Deniz Duman, Osman Ozdogan, Nese Imeryuz, Cem Kalayci - Show fewer authors

22 Dec 2005

Non-alcoholic fatty liver disease and metabolic syndrome: what we know and what we don't know.

Daad H. Akbar, Abeer H. Kawther

01 Nov 2004

Hyperlipidemia- Lower Targets, Greater Challenges

Ebrahim A Balbisi,